Metastatic Carcinoma to the Uterine Cervix
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Uterine Corpus Sarcoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
30
|
|
0.030 |
None |
1.000 |
3 |
|
1983 |
2018 |
Aortic Stiffness
|
phenotype |
|
Disease or Syndrome
|
61
|
11
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma, Large Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
90
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Weight Gain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
124
|
12
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Skin callus
|
disease |
Skin and Connective Tissue Diseases
|
Acquired Abnormality
|
154
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Teratoma
|
disease |
Neoplasms
|
Neoplastic Process
|
171
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Convulsions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
174
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Seizures, Focal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
210
|
15
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
MRSA - Methicillin resistant Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
222
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Basal-Like Breast Carcinoma
|
disease |
|
Neoplastic Process
|
245
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary cholangiocarcinoma of intrahepatic biliary tract
|
disease |
Neoplasms
|
Neoplastic Process
|
274
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Fanconi Anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
394
|
173
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Renal Insufficiency
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
615
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |